Table 2 Clinical events by group.
Outcomes | Overall | Untreated | Treated without SVR | Treated with SVR | |
|---|---|---|---|---|---|
Overall | |||||
Hepatocellular carcinoma | |||||
1-year | Rate, % | 0.7 | 1.3 | 0 | 0.3 |
Sample size | 1220 | 518 | 115 | 587 | |
3-year | Rate, % | 4.7 | 5.8 | 6.9 | 2.8 |
Sample size | 547 | 285 | 66 | 196 | |
5-year | Rate, % | 9.5 | 12.3 | 12.4 | 4.6 |
Sample size | 294 | 143 | 39 | 110 | |
All-cause mortality | |||||
1-year | Rate, % | 0.1 | 0.2 | 0 | 0.2 |
Sample size | 1298 | 567 | 121 | 610 | |
3-year | Rate, % | 1.3 | 1.7 | 0 | 0.9 |
Sample size | 752 | 398 | 92 | 262 | |
5-year | Rate, % | 2.9 | 4.6 | 1.1 | 0.9 |
Sample size | 507 | 258 | 68 | 181 | |
7-year | Rate, % | 6.1 | 9.8 | 4.6 | 0.9 |
Sample size | 310 | 170 | 38 | 102 | |
FIB-4 < 1.45 | |||||
Hepatocellular carcinoma | |||||
1-year | Rate, % | 0.4 | 0 | 0 | 0.8 |
Sample size | 229 | 86 | 25 | 118 | |
3-year | Rate, % | 1.2 | 1.9 | 0 | 0.8 |
Sample size | 109 | 47 | 14 | 48 | |
5-year | Rate, % | 1.2 | 1.9 | 0 | 0.8 |
Sample size | 47 | 17 | 7 | 23 | |
All-cause mortality | |||||
1-year | Rate, % | 0 | 0 | 0 | 0 |
Sample size | 242 | 95 | 25 | 112 | |
3-year | Rate, % | 0 | 0 | 0 | 0 |
Sample size | 155 | 64 | 19 | 72 | |
5-year | Rate, % | 0 | 0 | 0 | 0 |
Sample size | 101 | 42 | 13 | 46 | |
7-year | Rate, % | 1.3 | 3.1 | 0 | 0 |
Sample size | 56 | 26 | 10 | 20 | |
FIB-4 ≥ 1.45 to < 3.25 | |||||
Hepatocellular carcinoma | |||||
1-year | Rate, % | 0.2 | 0.6 | 0 | 0 |
Sample size | 440 | 150 | 45 | 245 | |
3-year | Rate, % | 2.6 | 4.6 | 3.3 | 0.7 |
Sample size | 183 | 72 | 26 | 85 | |
5-year | Rate, % | 4.7 | 7.9 | 8.2 | 0.7 |
Sample size | 106 | 40 | 17 | 49 | |
All-cause mortality | |||||
1-year | Rate, % | 0.2 | 0 | 0 | 0.4 |
Sample size | 462 | 161 | 47 | 254 | |
3-year | Rate, % | 1.9 | 2.5 | 0 | 1.8 |
Sample size | 244 | 103 | 33 | 108 | |
5-year | Rate, % | 3.3 | 4.7 | 3.0 | 1.8 |
Sample size | 169 | 66 | 25 | 78 | |
7-year | Rate, % | 5.6 | 8.6 | 8.4 | 1.8 |
Sample size | 100 | 42 | 14 | 44 | |
FIB-4 ≥ 3.25 | |||||
Hepatocellular carcinoma | |||||
1-year | Rate, % | 1.7 | 4.2 | 0 | 0.4 |
Sample size | 295 | 130 | 43 | 195 | |
3-year | Rate, % | 8.6 | 9.4 | 13.9 | 6.7 |
Sample size | 155 | 68 | 26 | 57 | |
5-year | Rate, % | 18.0 | 22.6 | 22.3 | 12.3 |
Sample size | 88 | 33 | 15 | 40 | |
All-cause mortality | |||||
1-year | Rate, % | 0 | 0 | 0 | 0 |
Sample size | 425 | 146 | 49 | 230 | |
3-year | Rate, % | 1.1 | 1.8 | 0 | 0.5 |
Sample size | 219 | 100 | 40 | 79 | |
5-year | Rate, % | 4.6 | 9.8 | 0 | 0.5 |
Sample size | 146 | 61 | 30 | 55 | |
7-year | Rate, % | 8.7 | 17.7 | 3.4 | 0.5 |
Sample size | 86 | 35 | 14 | 37 | |
